Objectives: To investigate the population structure, drug resistance mechanisms and plasmids of communityassociated Enterobacter cloacae complex (CA-ECC) isolates in China.
Introduction
Enterobacter spp. have emerged as important nosocomial pathogens in the last decade and are classified as one of the 'ESKAPE bugs'. 1 Among Enterobacter spp. the Enterobacter cloacae complex (ECC) is of major importance, accounting for 65%-75% of infections. 2 The ECC comprises at least five species (E. cloacae, Enterobacter kobei, Enterobacter asburiae, Enterobacter hormaechei and Enterobacter ludwigii) with different subspecies and the taxonomic status is consecutively updated. However, ECC species are often investigated at the complex level, which impedes our understanding of their clinical significance, epidemiology and drug resistance characterization at the species level. Species identification within the ECC is difficult and currently hsp60 typing is the most widely used method. hsp60 typing groups the ECC into 12 genetic clusters (I-XII) and one unstable sequence cluster (XIII); 3 some of these genetic clusters have been assigned to the named species and subspecies. 4 According to this typing method, E. hormaechei has been revealed as the predominant species both in the clinical setting and in the environment. [4] [5] [6] Due to the prevalence of ESBLs and carbapenemases in the constituent species, the ECC has become the third major drug-resistant Enterobacteriaceae species involved in nosocomial infections after Escherichia coli and Klebsiella pneumoniae. [7] [8] Studies covering the years 1998-2013 from different parts of the world all reveal high ESBL carriage within the ECC (36%-66.7%). [9] [10] [11] [12] [13] Recently, large surveillance studies from North and South America, and China report increasing levels (7.4%-17.4%) of carbapenemaseproducing ECC. [14] [15] [16] [17] The ECC intrinsically carries ampC genes, resulting in a constitutive production of the AmpC b-lactamase and is thus resistant to ampicillin, amoxicillin, amoxicillin/clavulanate, first-generation cephalosporins and cefoxitin. 18 Moreover, the ECC overproduces AmpC b-lactamases by derepression of a chromosomal gene or by the acquisition of a transferable ampC gene on plasmids or other mobile elements, conferring resistance to thirdgeneration cephalosporins. Of more concern, various ESBL and carbapenemase genes are widespread within the species. The most prevalent ESBL genotypes are bla CTX-M-9 , bla CTX-M-14 , bla CTX-M- 15 and bla SHV-12 .
11,13,19-21 KPC, NDM and IMP/VIM are the major types of carbapenemases. [14] [15] [16] [17] It has been suggested that conjugative plasmids are primarily responsible for the spread of these resistance genes among enterobacterial isolates; mainly six plasmid families (IncF, IncA/C, IncL/M, IncN, IncI and IncHI2). 22 MLST has revolutionized the clonal structure analyses of bacterial populations, allowing reliable large-scale epidemiological and evolutionary studies. Because of the relatively recent release of the MLST scheme for Enterobacter spp. (2013), only limited MLST data exist in the literature, largely impeding the understanding of the global epidemiology of ECC. Recently, multiple international clones (ST66, ST78, ST108 and ST114) that cause nosocomial infections were identified in Europe. [23] [24] [25] However, those clones have not been identified during our previous investigation in China, 19 suggesting that the epidemiology of nosocomially acquired ECC could depend on geography.
Of note, ECC strains have recently also become major pathogens involved in community-acquired infections, frequently causing pneumonia and urinary tract and bloodstream infections. [26] [27] [28] It has been suggested that the nosocomial isolates represent samplings from the diversity of commensal ECC in the community. 25 However, the epidemiological and drug resistance characterization of community-associated ECC (CA-ECC) is unclear, thus largely impeding verification of this hypothesis. This study was performed to investigate the population structure, drug-resistance mechanisms and plasmids of CA-ECC isolates collected in 31 hospitals in 12 provinces in China.
Materials and methods

Clinical isolates
Isolates were collected in the course of a national survey from 31 hospitals located in 12 provinces, representing seven geographical regions of China, between August 2010 and August 2011. 29 Patients with communityassociated infections were included in the study in accordance with previously described criteria. 29 Species identification was performed using MALDI-TOF MS (Bruker Diagnostics, Bremen, Germany) and the ECC members were differentiated by hsp60 typing. 3 
Antimicrobial susceptibility testing
Antimicrobial susceptibility was determined using the agar dilution method and the antibiotics are listed in Table 2 . Results were interpreted according to the 2016 EUCAST clinical breakpoints (http://www.eucast.org/clinical_ breakpoints/). Susceptibility to biapenem, cefoperazone/sulbactam and cefazolin was interpreted according to CLSI. 30 The breakpoints for biapenem and cefoperazone/sulbactam referred to those of imipenem and cefoperazone/sulbactam, respectively, as recommended by CLSI. The phenotypic detection of ESBL and AmpC expression was performed by the double-disc synergy test using cefotaxime and ceftazidime with clavulanate discs in the absence or presence of 250 mg/L cloxacillin.
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MLST and phylogenetic analysis MLST was performed as described previously 31 and the STs were assigned using the MLST database (http://pubmlst.org/ecloacae). The relatedness between the STs was analysed using eBURST (http://eburst.mlst.net/). The seven DNA fragments were concatenated; the phylogenic tree was constructed by bootstrap phylogenetic inference using MEGA6 v. 6.0. The sequences of 14 concatenated reference sequences (ST2, ST3, ST9, ST12, ST78, ST108, ST114, ST119, ST122, ST130, ST131, ST144, ST162 and ST187) were included in the phylogenetic analysis, corresponding to the previously identified main ST clades. 24 
Plasmid analysis
The plasmid size was estimated by S1-PFGE. The conjugative transfer of plasmids was carried out with the recipient E. coli J53 and a 2:1 donor:recipient ratio at 30 C. The transconjugants were selected on Mueller-Hinton medium with sodium azide (100 mg/L) and ceftriaxone (4 mg/L). The selected transconjugants were verified by replicon amplification using primers, as previously described; 32 the representative transconjugants were sent for WGS. Plasmid replicon typing was performed either as previously described 32 or by submitting the genomic sequences to PlasmidFinder (https://cge.cbs.dtu.dk/services/PlasmidFinder/). Plasmid sequences were compared using BLASTn.
WGS and data analysis
The genomes were sequenced using an Illumina Hiseq2500 instrument (Illumina, San Diego, CA, USA) after constructing 2%125 bp paired-end libraries. The de novo assembly was performed using CLC Genomics Workbench v. 8.0 (QIAGEN, Hilden, Germany) after quality trimming (Qs 20); the annotation was performed using the RAST server (rast.nmpdr.org); the resistome analysis was carried out using the CGE server (https://cge.cbs. dtu.dk) and CARD (https://card.mcmaster.ca/); and the detection of SNPs and synteny and phylogenomic analyses were performed as described previously.
33
Average nucleotide identity (ANI) analysis 
GenBank accession numbers
The Whole Genome Shotgun BioProject for the ECC isolates has been deposited at DDBJ/EMBL/GenBank under accession numbers NEEF00000000-NEEX00000000.
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Results
E. hormaechei and E. kobei were prevalent among CA-ECC
In this study, 62 ECC isolates were detected (isolates ECC3018, ECC3026 and ECC3047 have been reported previously) 34 among 2946 community-associated clinical isolates; they constituted 6.7% of the detected Enterobacteriaceae (n " 952) and 78.5% of the detected Enterobacter spp. (n " 79). These isolates were detected in seven geographical regions ( Figure S1 , available as Supplementary data at JAC Online) and were obtained from sputum (n " 23), urine (n " 17), secretions (n " 7), abscesses (n " 2), bronchoalveolar lavage (n " 1) and blood (n " 1), or unknown sources (n " 11).
The 62 isolates were identified by MALDI-TOF MS as E. cloacae (n " 35), E. asburiae (n " 14) and E. kobei (n " 13). The hsp60 typing revealed that E. hormaechei was predominant (n " 21), followed by E. kobei (n " 15), cluster IV (n " 7), cluster III (n " 6), cluster IX (n " 4), E. asburiae (n " 3), cluster XIII (n " 3), E. ludwigii (n " 2) and E. cloacae (n " 1) ( Table 1 ).
E. kobei is predominant in the ESBL-positive population
As summarized in Table 2 , all isolates exhibited low susceptibility rates to ampicillin (0%), ampicillin/sulbactam (24.2%), cefazolin (12.9%) and cefuroxime (30.6%), and high susceptibility rates to piperacillin/tazobactam (65.2%), cefoperazone/sulbactam (90.5%), ceftazidime (67.8%), amikacin (80.7%) and fluoroquinolones (ciprofloxacin: 72.5%; levofloxacin: 77.4%). All isolates were susceptible to carbapenems.
Of the 62 isolates, 22 (35.5%) exhibited an ESBL-positive phenotype ( Table 1) . Half of the ESBL-positive strains were E. kobei (n " 11), followed by E. hormaechei (n " 5).
Detection of an emerging ESBL-positive E. kobei clone in northern China
MLST assigned the 62 isolates to 46 STs (including 33 novel STs as of February 2016), indicating a high genetic diversity of the CA-ECC isolates. The most prevalent ST was ST591 (n " 8), followed by ST32 (n " 3), ST564 (n " 3), ST634 (n " 3), ST145 (n " 2), ST618 (n " 2) and ST629 (n " 2). The remaining STs contained one isolate for each (Table 1) . Clonality analysis suggested a polyclonal structure of the 46 STs ( Figure S2 ). Eight STs (ST32, ST90, ST145, ST542, ST582, ST875, ST876 and ST878) were classified into eight clonal complexes. Thirteen STs were connected with one or two STs, and the others were singletons. The 22 ESBL-positive isolates represented 11 STs (Table 1) . Little association was found between the ST prevalence and the specimen type or the geographical origin of the isolates. Notably, the eight ST591 E. kobei strains were obtained from two different regions (central north and northeast), suggesting that this ESBL-positive clone is circulating in northern China. ST32, ST145 and ST359 were also identified in different regions (Table 1 and Figure 1 ).
Phylogenetic analysis based on the concatenated sequences of seven MLST loci classified the 46 STs into 14 clusters (A-N), including 12 reported clusters (A-L) 24 and two novel clusters (M and N) ( Figure 1 ). Clusters A, B and C constituted the largest clade of 24 STs. Of note, cluster A and B isolates belonged to E. hormaechei and cluster C isolates belonged to cluster III, implying a close relationship between cluster III and E. hormaechei. The clusters identified by MLST correlated well with the hsp60 typing results (Figure 1 ).
Intra-and inter-regional dissemination of the ESBLpositive E. kobei clones
Core-genome phylogenetic analysis using 37113 SNPs classified the 22 ESBL-positive isolates into six clades (Figure 2 ). The 11 ESBLproducing E. kobei strains clustered with the type strain DSM13645 constitute the largest clade, with two subclades formed by ST591 and ST32. The ST591 isolates were clustered according to their origin, forming two different subclones differentiated by 190 SNPs (Figure 2 ). Of note, the central north clone was isolated at two hospitals and showed 1-7 SNPs, indicating clonal dissemination in the region. The three ST32 isolates obtained from the middle south (ECC1752 and ECC1875) and south-west (ECC1097) differed by 1-19 SNPs. Surprisingly, ECC1752 was identical to ECC1097 (no SNPs), suggesting inter-regional transmission.
In another large clade composed of E. hormaechei strains, ECC904 and ECC1950 were clustered with E. hormaechei subsp. steigerwalltii DSM16691, while ECC3422 clustered with E. xiangfangensis LMG27195, a new subspecies of E. hormaechei. 4 These two subclades differed by .2960 SNPs and were separated from a subclade of two cluster III strains (ECC1840 and ECC3137) by .4760 SNPs. The E. hormaechei clade further grouped with the cluster XIII strain ECC1766, which suggests that they share a common ancestor.
The three cluster IV strains (ECC4202, ECC4240 and ECC4241) grouped with the type strain E. asburiae ATCC 35953. The three isolates were almost identical with 1 SNP, indicating clonal dissemination in the central south. The E. cloacae isolate ECC2288 clustered with E. cloacae subsp. cloacae ATCC 13047, and further clustered with E. ludwigii EN119, suggesting that they share a common ancestor. The cluster IX strain ECC2572 represented a singleton.
CTX-M-3 and SHV-12 are the prevalent genotypes
ESBL genes were detected in 15 of the 22 ESBL-positive isolates, with bla CTX-M-3 the most prevalent (n " 10), followed by bla SHV-12 (n " 7), bla CTX-M-9 (n " 3), bla CTX-M-12 (n " 3) and bla CTX-M-14 (n " 2) (Figure 2 ). These ESBL genes were found in E. kobei (n " 11), E. hormaechei (n " 2) and cluster III (n " 2). Two types of AmpC b-lactamase genes, bla ATC and bla MIR , were detected in the majority of ESBL-positive isolates, with the exception of ST32 strains. The AmpC-overexpression phenotype was apparent in 18 ESBLproducing strains, including the seven strains lacking the ESBL genes ( Figure 2 ). The AmpC-overexpression phenotype can be explained by multiple point mutations detected in ampR and ampD genes in the 18 strains (data not shown).
Differences in the resistome and drug susceptibility between the ESBL-producing and non-ESBL-producing isolates in the ESBL-positive population
We next analysed the resistomes of the ESBL-positive isolates. The 15 ESBL-producing isolates harboured many more drug-resistance Zhou et al. 
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Characterization of community-associated E. cloacae in China JAC genes (8-24 genes) than the seven ESBL-positive isolates lacking the ESBL genes (3-4 genes) ( Figure 3 ). In agreement with their genotypes, significant differences in antibiotic susceptibility were observed between the two groups. The ESBL producers were non-susceptible to amikacin (MIC value: 8 to .256 mg/L; ECC3137 was susceptible), gentamicin (8 to .256 mg/L), ciprofloxacin (4 to 32 mg/L; ECC3018, 3026 and 3047 were susceptible) and cefepime (8 to 64 mg/L), whereas the non-ESBL producers were susceptible (amikacin: 0.5 to 2 mg/L; gentamicin: 0.05 to 1 mg/L; ciprofloxacin: 0.03 to 0.125 mg/L; cefepime: 0.03 to 4 mg/L). Additionally, numerous genes associated with MDR efflux pumps were found in all isolates (Table S1) , with no significant differences between the two groups.
Genetic environment of bla CTX-M-3
Four different types of genetic environments of bla CTX-M-3 were observed in 10 isolates (Figure 4) . In all these genetic Zhou et al.
environments, the varying-length ISEcp1 was located 127 bp upstream of bla CTX-M-3 in the same orientation. In addition, the ISEcp1-bla CTX-M-3 transposition units were found in six different wider contexts.
IncHI2/2A plasmids are prevalent among the ESBL producers
Replicon typing identified numerous plasmid incompatibility (Inc) groups in 21 of the 22 ESBL-positive isolates, including IncHI (n " 13), IncA/C2 (n " 4), IncFIB (n " 9), IncFII (n " 4), IncFII (pECLA) (n " 3), IncL/M (n " 2), IncQ (n " 1), IncCol (RGK) (n " 1), IncN (n " 1), IncR (n " 1) and IncpSL483 (n " 1). Of note, IncHI (especially IncHI2/2A) was almost exclusively detected in the ESBL-producing isolates (n " 12). Conjugation assays demonstrated that most of the IncHI2/2A plasmids (11/12) were mobilizable. We therefore suspected that IncHI2/2A could be the major plasmid type mediating ESBL community dissemination in China.
To verify this, the location of ESBL genes was inspected by sequencing of the conjugators harbouring one plasmid each. Except for the bla CTX-M-12 gene, 34 the other ESBL genes were all detected on plasmids (Table 3 ). Specifically, most ESBL genes were carried on IncHI2/2A plasmids. The backbone analysis revealed that all IncHI2/2A plasmids shared a similar backbone to an IncHI2/2A plasmid p09-036813-1A_261 (Genbank accession number CP016526) recovered from Salmonella enterica in Canada ( Figure 5 ).
Taxonomic status of the ECC determined by ANI
The ANI analysis was performed to determine the taxonomic status of cluster III, IV, IX and XIII. The ANI values of two cluster III strains ECC1840 and ECC3137 were .95% (95.52%-95.78%) versus the type strains E. hormaechei subsp. oharae DSM16687 and E. hormaechei subsp. steigerwalltii DSM16691, but ,95% (94.21%-94.37%) versus E. hormaechei subsp. hormaechei ATCC Characterization of community-associated E. cloacae in China JAC 49162. This suggests that cluster III is a novel subspecies of E. hormaechei. The ANI values of the three cluster IV strains were 92.96% versus the type strain E. asburiae ATCC 35953, suggesting that cluster IV is a novel ECC species, closely related to E. asburiae according to the core-genome phylogeny (Figure 2) . Furthermore, the ANI values of cluster IX strain ECC2572 and cluster XIII strain ECC1766 were ,92% (87.73-91.55% and 86.87-90.16%, respectively) versus all available type strains, indicating that they are novel species of the ECC.
Discussion
The ECC includes multiple phylogenetically closely related species, resulting in a complicated taxonomic status. Accurate identification of ECC species by either phenotypic or genotypic methods is challenging. To date, hsp60 typing is the only PCRbased method available for ECC species identification. Interestingly, our study revealed that the phylogeny based on concatenating the sequences of seven MLST loci corresponds to the Zhou et al.
results of hsp60 typing, albeit resulting in a higher resolution (i.e. more clusters). We therefore suggest that hsp60 typing can be replaced by the phylogenic analysis of MLST for ECC species identification in the future, since MLST but not hsp60 typing is routinely performed in most laboratories.
The ECC species are often investigated at the complex level, thus largely impeding our understanding of their epidemiology and clinical significance at the species/subspecies level. In this study, E. hormaechei (33.9%) and E. kobei (24.2%) were identified as the predominant species among 62 CA-ECC strains collected across China. Although this is consistent with E. hormaechei being the most prevalent species in the clinical setting, 4, 5, 35 to the best of our knowledge, this is the first report identifying E. kobei as the predominant species within the ESBL-positive population, with a higher prevalence than E. hormaechei (50% versus 22.7%). Of more concern, dissemination of the ESBL-producing E. kobei clone ST591 was identified in northern China and SNP analysis additionally supports an inter-regional transmission of an ESBLproducing E. kobei clone ST32 between the middle south and the south-west. These results suggest that surveillance is required for controlling further spread of ESBL-producing E. kobei clones in China. Additionally, very few epidemiological data are available for E. kobei, probably due to its infrequent detection in the clinical setting. The limited information does not allow us to conclude whether this distribution is specific to community-associated infections or to the geographical epidemiology (i.e. China). More data are needed to understand the epidemiology of E. kobei in the future.
Before the current study, the drug-resistance profiles and clonality of CA-ECC on a national scale in China was unclear. We report here a high level of ESBL; 35.5% of CA-ECC. This is comparable with CA-E. coli (46.5%) and CA-K. pneumoniae (31.8%) from the same surveillance project, 36, 37 whereas the prevalent ESBL genotypes differed among CA-ECC (bla CTX-M-3 ), CA-E. coli (bla CTX-M-14 ) and CA-K. pneumoniae (bla CTX-M-15 ). Additionally, bla CTX-M-9 was previously detected as the most prevalent ESBL gene in nosocomially acquired ECC in China 19 and bla CTX-M-9 and bla CTX-M-15 in other Characterization of community-associated E. cloacae in China JAC countries. 13, 24, 38, 39 This indicates that the ESBL genotype of community-associated and nosocomially acquired ECC could be different. Currently, little is known about the clonality and/or global epidemiology of the ECC due to the relatively late establishment of the MLST scheme. More recently, international high-risk clones (ST66, ST78, ST108 and ST114) were detected in European countries. [23] [24] [25] However, none of these high-risk clones was found in the current study or our previous study, 19 indicating that the epidemiological characterization of the ECC could be geographically specific.
Intriguingly, we found a significant inter-species variation of the ESBL mechanism among the ESBL-positive ECC population. All ESBL producers were exclusively identified as E. kobei and E. hormaechei, while the ESBL-positive isolates of other species were caused by AmpC overexpression. Likewise, a recent study reports that colistin hetero-resistance of ECC is dependent on the cluster/species. 40 We further observed a significant inter-group difference in drug susceptibilities among the ESBL-positive isolates. Such a difference might significantly compromise clinical treatment, thus emphasizing the necessity of species-level identification of ECC in clinical settings. Additionally, all ESBL-positive isolates caused by AmpC overexpression encoded a very limited repertoire of resistance genes, since they carried no or only one plasmid. However, the ESBL-producing isolates harboured multiple plasmids, resulting in an MDR phenotype. Such broad-spectrum antibiotic resistance conferred by plasmids greatly facilitates the dissemination of ESBL genes in the hospital environment and thus affects the inter-species distribution diversity in clinical settings. Taken together, our results suggest that tailored surveillance at the species level is necessary for efficient control of the spread of drug-resistant ECC.
Although the ECC is one of the most important ESBL producers, unlike E. coli and K. pneumoniae, no epidemic ESBL-producing plasmids have yet been identified in the ECC. In this study, we identified that IncHI2 is the major plasmid type responsible for the dissemination of ESBL genes in the CA-ECC in China. We further found that the IncHI2-type plasmids were also prevalent among the nosocomially acquired ESBL-producing ECC (18/27) (data not shown). This is consistent with two previous studies showing that IncHI2-type plasmids are responsible for the dissemination of CTX-M genes in nosocomially acquired ECC isolates in Norway and Spain. 41, 42 Taken together, the IncHI2-type plasmids may act as an important reservoir mediating the dissemination of CTX-M genes in ECC populations worldwide.
IncHI2-type plasmids are frequently involved in the acquisition of various antibiotic resistance genes in isolates of human and animal origin. [43] [44] [45] [46] All IncHI2 plasmids identified in this study shared a similar backbone to the one recovered from S. enterica in Canada. This indicates that IncHI2 could act as a major vector transferring the resistance genes between human and animals. Further, IncHI2 frequently carries carbapenemase genes, especially bla VIM- Zhou et al.
.
47-50 It would not be surprising if the ESBL-producing ECC isolates carrying IncHI2 plasmids would easily become carbapenem resistant by acquiring integron-borne carbapenemase genes in the future.
In conclusion, the detected high ESBL rate in the CA-ECC in China, especially the clonal dissemination of E. kobei identified in certain regions, suggests that tailored surveillance of this species is necessary in the future. The inter-species difference in drug susceptibility is mainly associated with the diverse ESBL mechanisms among the ECC population. Particular attention should be paid to the wide spread of IncHI2-type plasmids, which could be a reservoir of carbapenemase genes in the future.
